Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.95 |
| ▸ | MAPT | P10636 | 9/20 | 0.95 |
| ▸ | GAA | P10253 | 4/20 | 0.95 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.95 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.95 |
| ▸ | HTT | P42858 | 3/20 | 0.95 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.95 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.95 |
| ▸ | MEN1 | O00255 | 2/20 | 0.95 |
| ▸ | POLB | P06746 | 2/20 | 0.95 |
| ▸ | NPC1 | O15118 | 1/20 | 0.95 |
| ▸ | USP2 | O75604 | 1/20 | 0.95 |
| ▸ | TP53 | P04637 | 1/20 | 0.95 |
| ▸ | THRB | P10828 | 1/20 | 0.95 |
| ▸ | RECQL | P46063 | 1/20 | 0.95 |
| ▸ | RAB9A | P51151 | 1/20 | 0.95 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.95 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.95 |
| ▸ | LMNA | P02545 | 5/20 | 0.61 |
| ▸ | GFER | P55789 | 4/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6608042 | 1.00 | ALDH1A1 (0.95) | ALDH1A1MAPTGAAKDM4EL3MBTL1 | |
| SCHEMBL1986101 | 1.00 | ALDH1A1 (0.95) | ALDH1A1MAPTGAAKDM4EL3MBTL1 | |
| Hydrochloric Acid SCHEMBL9014036 | 0.98 | ALDH1A1 (1.00) | ALDH1A1MAPTGAAKDM4EL3MBTL1 | |
| SCHEMBL33852 | 0.97 | ALDH1A1 (0.91) | ALDH1A1MAPTGAAKDM4EL3MBTL1 | |
| Hydrochloric Acid SCHEMBL1153999 | 0.95 | ALDH1A1 (0.95) | ALDH1A1MAPTGAAKDM4EL3MBTL1 | |
| SCHEMBL7130594 | 0.93 | ALDH1A1 (0.83) | ALDH1A1MAPTGAAKDM4EL3MBTL1 | |
| SCHEMBL1858354 | 0.92 | ALDH1A1 (0.82) | ALDH1A1MAPTGAAKDM4EL3MBTL1 | |
| SCHEMBL7128309 | 0.91 | ALDH1A1 (0.79) | ALDH1A1MAPTGAAKDM4EL3MBTL1 | |
| SCHEMBL112440 | 0.90 | MAPT (0.78) | ALDH1A1MAPTGAAKDM4EL3MBTL1 | |
| Hydrochloric Acid SCHEMBL5169602 | 0.88 | MAPT (0.83) | ALDH1A1MAPTGAAKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114349749-B | Synthesis method of apixaban | 南京正科医药股份有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-113072937-B | Lipid drop targeted carbon dot, preparation method and application | 郑州大学 | 2022-06-07 | — | — | CN | claimed |
| CN-114349749-A | Synthesis method of apixaban | 南京正科医药股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-109678788-B | 1, 2-diaryl indole, derivative and synthetic method thereof | 湘潭大学 | 2021-05-04 | — | — | CN | claimed |
| CN-109678788-A | A kind of 1,2- diaryl indoles, derivative and its synthetic method | 湘潭大学 | 2019-04-26 | — | — | CN | claimed |
| CN-106619701-A | Western medicine composition for treating coronary heart disease and preparation method thereof | 郑州郑先医药科技有限公司 | 2017-05-10 | — | — | CN | claimed |
| EP-2611797-B1 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | HANMI SCIENCE CO LTD (KR) | 2016-12-28 | — | — | EP | claimed |
| US-8835458-B2 | Quinoline or quinazoline derivatives with apoptosis inducing activity on cells | HANMI SCIENCE CO., LTD (KR) | 2014-09-16 | — | — | US | claimed |
| US-20140200354-A1 | Process for the Manufacture of Non-Steroidal Anti-Inflammatory Agents and Intermediates Thereof | INTENDIS GMBH (DE) | 2014-07-17 | — | — | US | claimed |
| CN-101679247-B | Process for preparing non-steroidal anti-inflammatory drugs and intermediates thereof | INTENDIS GMBH | 2014-02-19 | — | — | CN | claimed |
| US-4865619-A | Use, as a coupler, of 2,4-diamino-1,3-dimethoxybenzene or one of its salts, in combination with oxidation dye precursors, for dyeing human hair, hair dyeing composition containing the said coupler and process for preparing the said coupler | L'OREAL (FR) | 1989-09-12 | — | — | US | claimed |
| US-4865618-A | New chloro-meta-phenylenediamines, their use as couplers in the oxidation dyeing of keratinous fibres, dyeing compositions for hair containing these compounds and dyeing process using the said | L'OREAL (FR) | 1989-09-12 | — | — | US | claimed |
| US-4865617-A | Dyeing compositions for keratinous fibres, especially for human hair, containing oxidation dye precursors and heterocyclic couplers | L'OREAL (FR) | 1989-09-12 | — | — | US | claimed |
| EP-0295474-A1 | Chlorometaphenylenediamines, their use as coupling agents in oxydation colouring of keratinic fibres, colourity compositions for hair containing these compounds and colouring process using these compositions | L'OREAL (FR) | 1988-12-21 | — | — | EP | claimed |
| EP-0294669-A1 | Metaphenylendiamines, process for their preparation, intermediate compounds and use of these metaphenylendiamines as couplers in oxydative colouring of keratinic fibres especially of human hair | L'OREAL (FR) | 1988-12-14 | — | — | EP | claimed |
| US-4692166-A | OXIDATION COLOR DYES USED WITH DIAMINOBENZENES OR AMINO PHENOLS; MINIMIZATION OF RED HUE | L'OREAL (FR) | 1987-09-08 | — | — | US | claimed |
| US-4337061-A | NITRO DYES IN AQUEOUS SOLUTION | SOCIETE ANONYME DITE: L'OREAL (FR) | 1982-06-29 | — | — | US | claimed |
| US-4200432-A | HAIR DYES | L'OREAL (FR) | 1980-04-29 | — | — | US | claimed |
| US-3961879-A | P-PHENYLENEDIAMINE, HAIR | L'OREAL (FR) | 1976-06-08 | — | — | US | claimed |
| US-3948596-A | Oxidation dye for keratinic fibers containing 2-halo-5-acetaminophenol as a coupler | SOCIETE ANONYME DITE: L'OREAL (FR) | 1976-04-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140200354-A1 | Process for the Manufacture of Non-Steroidal Anti-Inflammatory Agents and Intermediates Thereof | CYP2F1, CYP4A11, CYP11B1 | ALDH1A1 1720/4885MAPT 4769/4885GAA 3767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.